Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Shire appoints new member of board of directors

Shire appoints new member of board of directors

7th September 2012

Shire has announced the appointment of Dr Steven Gillis as the newest member of its board of directors.

Dr Gillis will join the company on October 1st 2012 and is also set to become a member of the firm's remuneration and science and technology committees, bringing extensive immunology expertise to Shire.

He is the current managing director of Arch Venture Partners and is the former founder and director of the healthcare companies Corixa and Immunex.

The medical expert has also authored more than 300 peer-reviewed publications in the areas of molecular and tumour immunology, earning him recognition as a pioneer in the field of cytokines and cytokine receptors.

Shire chairman Matt Emmens said: "Steven's pioneering and entrepreneurial approach paired with a deep technical and scientific knowledge will complement the existing skills and outlook of the Shire board. I look forward to him joining in the autumn."

Last month, the company became a full member of the Association of the British Pharmaceutical Industry, in order to increase its influence in the UK market.ADNFCR-8000103-ID-801444519-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.